Was this the data GILD looked at when they purchas
Post# of 155578
https://www.nejm.org/doi/10.1056/NEJMoa1814213
It was a phase 1b/2 like us with slightly more people enrolled.
Will we have a published paper in NEJM? I don’t believe we have anything published there yet. Why ?
I rly want to see our data on TNBC. It sounds too good to be true that we will beat the SOC? Depending on our results alone we are worth more than the drug they purchased. Our trial was smaller but not by too much.
Yet we sit at .50. Does the market not trust the PR on TNBC? If they did we should be trading way higher or is the market waiting for more confirmation on these results. Like BTD from the FDA.
Thoughts ?


CytoDyn Inc (CYDY) Stock Research Links
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com